# Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

> **NCT02413268** · PHASE3 · UNKNOWN · sponsor: **Total Cardiovascular Solutions** · enrollment: 2400 (estimated)

## Conditions studied

- Total Atherosclerotic Occlusion of Radial Artery

## Interventions

- **DRUG:** Nitroglycerin

## Key facts

- **NCT ID:** NCT02413268
- **Lead sponsor:** Total Cardiovascular Solutions
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02413268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02413268, "Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02413268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*